logo
Plus   Neg
Share
Email

Vodafone Halts Purchase Of Huawei Equipment

vodafone huawei 012519 lt

Vodafone Group plc (VOD,VOD.L) said Friday it is suspending the purchase of components made by Chinese tech giant Huawei Technologies Co. Ltd. for its core telecom networks. The announcement marks the latest setback for Huawei amid worries that the company's telecom equipment poses security risks.

Vodafone said it will "pause" the purchase of Huawei gear for use in its 5G networks amid uncertainty over whether some governments in Europe will ban the Chinese company.

"Given that, we have decided to pause further Huawei in our core whilst we engage with the various agencies and governments and Huawei just to finalise the situation, of which I feel Huawei is really open and working hard," Chief Executive Officer Nick Read said.

Read added that the suspension of Huawei equipment purchases would affect only its European networks, though his company uses Huawei equipment in Spain and other smaller markets.

Several countries, including the U.S., Japan, Australia and New Zealand, have already banned Huawei from supplying equipment for their domestic telecom networks.

The U.S. has serious concerns about the security risks posed by Chinese technology companies, including Huawei and fellow Chinese telecommunications firm ZTE.

Intelligence agencies are concerned that Huawei and other Chinese companies may be beholden to the Chinese government or the ruling Communist Party, raising the risk of espionage.

The U.S. government has initiated an extraordinary outreach campaign to foreign allies, trying to persuade wireless and Internet providers in these countries to avoid telecommunications equipment from Huawei.

Federal prosecutors in the U.S. are also reportedly pursuing a criminal investigation of Huawei for allegedly stealing trade secrets from U.S. partners.

Sabrina Meng Wanzhou, the Chief Financial Officer of Huawei Technologies Co., was arrested in Canada in December 2018 on charges of violating U.S. trade sanctions against Iran.

Meng Wanzhou, who is the daughter of the Chinese telecommunication giant's founder, faces extradition to the U.S. to face fraud charges, which she denies.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
JPMorgan Chase CEO Jamie Dimon said it expects the bank's earnings to be "down meaningfully" in 2020 due to the disruptions created by coronavirus pandemic. He also noted that the U.S. was not adequately prepared for the pandemic. In his annual letter to the company's shareholders, Dimon said that the bank's board may consider suspending the dividend in an extremely adverse scenario. The U.S. Food and Drug Administration launched a national effort to facilitate the development of blood-related therapies to combat the ongoing coronavirus (COVID-19) pandemic. The FDA is focused on two investigational therapies derived from human blood called convalescent plasma and hyperimmune globulin, which are antibody-rich blood products made from blood donated by people who have recovered. Gilead Sciences Inc. said it is donating its existing supply of 1.5 million individual doses of remdesivir, its investigational medicine for coronavirus or Covid-19. The drug, which is yet to get regulatory approval, is available for compassionate use, expanded access and clinical trials to treat patients with the most severe symptoms of COVID-19.
Follow RTT
>